Hong-Hong Xue1, Yuan-Yuan Wang2. 1. Department of Ultrasound, Yanan University Affiliated Hospital. 2. Department of Breast Surgery, Yan'an People's Hospital, Yan'an, Shaanxi, China.
Abstract
BACKGROUND: This study aims to explore the association between shear wave elastography parameters (SWEPs) and clinicopathological characteristics (CPCs) in breast cancer (BC). METHODS: The electronic databases of Cochrane Library, MEDLINE, EMBASE, Allied and Complementary Medicine Database, WANGFANG, VIP, and China National Knowledge Infrastructure will be used to search for studies dated from database inception to the present. No limitations of language and publication status will be applied in this study. Only case-controlled study and randomized controlled trials investigating the association between SWEP and CPC in BC will be included. Cochrane risk of bias will be used to assess study quality for each included study. RevMan 5.3 software will be utilized for statistical analysis. RESULTS: This study will provide accurate data to appraise the association between SWEP and CPC in BC. CONCLUSION: This study will summarize the most recent evidence to improve our understanding of the association between SWEP and CPC in BC. OSF REGISTRATION NUMBER:: osf.io/vmkwu.
BACKGROUND: This study aims to explore the association between shear wave elastography parameters (SWEPs) and clinicopathological characteristics (CPCs) in breast cancer (BC). METHODS: The electronic databases of Cochrane Library, MEDLINE, EMBASE, Allied and Complementary Medicine Database, WANGFANG, VIP, and China National Knowledge Infrastructure will be used to search for studies dated from database inception to the present. No limitations of language and publication status will be applied in this study. Only case-controlled study and randomized controlled trials investigating the association between SWEP and CPC in BC will be included. Cochrane risk of bias will be used to assess study quality for each included study. RevMan 5.3 software will be utilized for statistical analysis. RESULTS: This study will provide accurate data to appraise the association between SWEP and CPC in BC. CONCLUSION: This study will summarize the most recent evidence to improve our understanding of the association between SWEP and CPC in BC. OSF REGISTRATION NUMBER:: osf.io/vmkwu.
Breast cancer (BC) is the most common type of cancer in female population worldwide.[ It is also the leading cause of cancer-related mortality and morbidity.[ In China, it is the most frequently diagnosed cancer in females over 30 years of age.[ It is reported that there were 1.38 million new cases of invasive BC identified globally in 2008. Patients with BC are often discovered by routine screening, and it often manifests as breast lump, change of breast shape and size, as well as nipple discharge.[ Several risk factors are responsible for BC, such as age, gender, personal history of BC, family history of BC, histologic, genetic, and reproductive risk factors, and exogenous hormone use.[Studies reported that ultrasound shear wave elastography (SWE) can supply novel insights into the shear elastic modulus of soft tissues.[ It can be used to detect differences between healthy and pathological tissues.[ It is reported that ultrasound SWE has used for the detection of patients with BC.[ However, no study has performed the association between SWE parameters (SWEPs) and clinicopathological characteristics (CPCs) in BC. Thus, this study will explore this issue systematically and comprehensively.
Methods
Study registration
We have registered this study on OSF (osf.io/vmkwu), and we have reported it according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol statement guidelines.[
Ethics and dissemination
The ethical approval is waived in this study, because this study will use published patient data. This study is expected to be published in a peer-reviewed journal or present in a relevant conference.
Eligibility criteria
Types of studies
All case-controlled study (CCS) or randomized controlled trials (RCTs) on exploring the association between SWEP and CPC in BC will be considered for inclusion in this study. All other studies, such as animal study, nonclinical study, and noncontrolled trial will be excluded.
Types of interventions
Experimental group: we will include studies that involved the lump of breast in patients with BC.Control group: we will include studies that involved adjacent tissue of attacked breast for examination.
Types of participants
We will include patients who were diagnosed as BC, regardless their country, race, age, gender, and educational or economic status.
Types of outcome measurements
Outcomes include lump hardness parameters (maximum elastic modulus, average, standard deviation), lesion size, pathological type, and axillary lymph node metastasis.
Information sources
A literature search will be conducted at Cochrane Library, MEDLINE, EMBASE, Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure since their inception to the present. No language limitation is applied to all electronic databases. In addition, we will also search websites of clinical trial registry, conference proceedings, dissertations, and reference lists of included studies. A sample of search strategy for PUBMED is presented in Table 1. We will also adapt similar search strategy to other electronic databases.
Table 1
Search strategy of PubMed.
Number
Search terms
1
breast cancer
2
breast carcinoma
3
breast tumor
4
breast lump
5
Or 1–4
6
shear wave elastography
7
Ultrasound
8
shear elastic modulus
9
Operation
10
clinicopathological characteristics
11
Pathological
12
Parameters
13
Association
14
Or 6–13
15
Random
16
Randomly
17
controlled trial
18
clinical trial
19
Blind
20
Allocation
21
case-control
22
case-controlled
23
case-reference
24
Study
25
Trial
26
Or 15–25
27
5 and 14 and 26
Search strategy of PubMed.
Selection of studies
Two authors will independently scan the searched records using titles and abstracts. Any duplicated and irrelevant studies will be removed. Then, they will go through the full papers of the remaining studies in order to determine whether they finally meet all inclusion criteria. Any discrepancies between 2 authors will be solved by a third author through discussion. The process of study selection is summarized in a flowchart.
Data extraction and management
Two authors will independently extract the data according to the previously designed data extraction sheet that includes basic study details (such as author names, publication time, location, and so on), patient characteristics (such as age, sex, sample size, inclusion and exclusion criteria, and so on), study setting, study methods, index details, outcomes, results, findings, conflict of interest, and funding information. Any disagreements will be solved through discussion and will provide final judgment with the help of a third author if necessary.
Study quality assessment
Two authors will independently assess study quality for all included RCTs using Cochrane Risk of Bias Tool and all eligible CCS using Newcastle--Ottawa Scale. If any divergences occur between 2 authors, a third author will be invited to solve them by discussion.
Measures of treatment effect
We will utilize mean difference (MD) or standard MD and 95% confidence intervals (95% CIs) for continuous data, and will express risk ratio and 95% CIs for dichotomous data.
Heterogeneity identification
The heterogeneity among the study results will be assessed using I2 statistic. A value of I2 ≤ 50% exerts a low level of heterogeneity, whereas a value of I2 > 50% indicates an obvious level of heterogeneity.
Statistical analysis
Data synthesis
In this study, statistical analysis will be carried out using RevMan 5.3 software. We will use a fixed-effects model if a low level of heterogeneity is found. We will consider to perform a meta-analysis if at least 2 studies on the same outcome with sufficient similarity are included. Otherwise, we will use a random-effects model if a substantial level of heterogeneity is identified. In addition, we will carry out subgroup analysis to explore any possible causes for such substantial heterogeneity. Whenever it is necessary, we will also plan to undertake a narrative summary description by presenting detailed written commentary on different study information, participant characteristics, and outcomes.
Subgroup analysis
A subgroup analysis will be performed based on the different study information, patient characteristics, index details, and outcome measurements.
Sensitivity analysis
We will carry out a sensitivity analysis in order to determine whether the outcome results are stability by removing studies with a high risk of bias.
Reporting bias
If 10 or more eligible publications will be found, funnel plot and Egger regression test will be conducted to check any potential reporting bias.[
Discussion
BC is a very commonly diagnosed cancer in female population, which significant impacts their health-related quality of life. Patients with such disorder often have high mortality and morbidity rates. However, it is not easy to detect this condition at very early stage. Fortunately, ultrasound SWE has reported to detect differences between healthy and pathological tissues.[ Although several studies explored the association between SWEP and CPC in patients with BC, no systematic review has undertaken this topic. This study will systematically and comprehensively investigate the association between SWEP and CPC in BC. We expect that our study will provide evidence to improve our understanding of the association between SWEP and CPC in BC.